Clough Capital Partners L P Dexcom Inc Transaction History

Clough Capital Partners L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $2.86 Million - $3.5 Million	-25,014 Reduced 19.64%	102,357 $14.2 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $1.49 Million - $2.46 Million	19,791 Added 18.4%	127,371 $15.8 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $9.26 Million - $14.8 Million	107,580 New	107,580 $10 Million
Q2 2022 Aug 16, 2022	SELL	$67.99 - $132.89 $278,759 - $544,849	-4,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $385,728 - $533,820	4,100 New	4,100 $2.1 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.